In a xenograft model of acute lymphoblastic leukemia (ALL), MSC-PTX showed the anti-angiogenic ability mediated by down-regulating some adhesion molecules such as ICAM1 and VCAM1 (128). This evidence concerns the gene ICAM1 and acute lymphoblastic leukemia.